Log In
Print
BCIQ
Print
Print this Print this
 

ProHema

  Manage Alerts
Collapse Summary General Information
Company Fate Therapeutics Inc.
DescriptionHematopoietic stem cells modulated with FT1050, a small molecule prostaglandin E2 analog
Molecular Target
Mechanism of Action 
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today